reports
- GlobalData Healthcare Department
Solon Eiendom ASA (BIONOR) - Pharmaceuticals & Healthcare - Deals and ...
Summary Solon Eiendom ASA (Solon Eiendom), formerly Bionor Pharma ASA, is a biopharmaceutical company focuses on development of proprietary therapeutic vaccine Vacc-4x. It develops vaccines for HIV and other deadly viruses. Solon Eiendom by utilizing its proprietary technology platform develops modified peptide based vaccines targeting rapidly mutating viruses. Its pipeline product portfolio includes four different vaccine candidates, namely, Vacc-4x, Vacc-C5, Vacc-HIV (combination of Vacc-4x a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.